MetLife Investment Management’s NuVasive, Inc. NUVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-28,150
| Closed | -$1.17M | – | 3014 |
|
|
2023
Q2 | $1.17M | Buy |
28,150
+517
| +2% | +$21.2K | 0.01% | 1176 |
|
|
2023
Q1 | $1.14M | Hold |
27,633
| – | – | 0.01% | 1162 |
|
|
2022
Q4 | $1.14M | Sell |
27,633
-32,363
| -54% | -$1.31M | 0.01% | 1153 |
|
|
2022
Q3 | $2.63M | Buy |
59,996
+377
| +0.6% | +$18.3K | 0.02% | 758 |
|
|
2022
Q2 | $2.93M | Sell |
59,619
-1,575
| -3% | -$84.5K | 0.02% | 734 |
|
|
2022
Q1 | $3.47M | Buy |
61,194
+17,640
| +41% | +$937K | 0.02% | 744 |
|
|
2021
Q4 | $2.29M | Buy |
43,554
+251
| +0.6% | +$13.6K | 0.02% | 820 |
|
|
2021
Q3 | $2.59M | Sell |
43,303
-988
| -2% | -$60.9K | 0.02% | 734 |
|
|
2021
Q2 | $3M | Sell |
44,291
-2,482
| -5% | -$169K | 0.03% | 674 |
|
|
2021
Q1 | $3.07M | Sell |
46,773
-3,452
| -7% | -$207K | 0.03% | 661 |
|
|
2020
Q4 | $2.83M | Sell |
50,225
-1,281
| -2% | -$63K | 0.03% | 651 |
|
|
2020
Q3 | $2.5M | Sell |
51,506
-2,528
| -5% | -$136K | 0.03% | 622 |
|
|
2020
Q2 | $3.01M | Buy |
54,034
+2,126
| +4% | +$123K | 0.03% | 532 |
|
|
2020
Q1 | $2.63M | Hold |
51,908
| – | – | 0.04% | 489 |
|
|
2019
Q4 | $4.01M | Sell |
51,908
-1,661
| -3% | -$117K | 0.04% | 463 |
|
|
2019
Q3 | $3.4M | Sell |
53,569
-469
| -0.9% | -$29.3K | 0.04% | 532 |
|
|
2019
Q2 | $3.16M | Buy |
54,038
+532
| +1% | +$31.4K | 0.03% | 588 |
|
|
2019
Q1 | $3.04M | Buy |
53,506
+120
| +0.2% | +$6.38K | 0.03% | 610 |
|
|
2018
Q4 | $2.65M | Sell |
53,386
-126
| -0.2% | -$7.58K | 0.03% | 626 |
|
|
2018
Q3 | $3.8M | Sell |
53,512
-2,394
| -4% | -$152K | 0.04% | 523 |
|
|
2018
Q2 | $2.91M | Buy |
55,906
+230
| +0.4% | +$12K | 0.03% | 628 |
|
|
2018
Q1 | $2.91M | Sell |
55,676
-261
| -0.5% | -$13.2K | 0.03% | 625 |
|
|
2017
Q4 | $3.27M | Buy |
+55,937
| New | +$3.17M | 0.04% | 596 |
|
Other funds holding NUVA
MetLife Investment Management's NUVA Position: Q3 2023 in Review
MetLife Investment Management sold out of NuVasive, Inc. (NUVA) in Q3 2023, closing a stake of 28,150 shares — an estimated $1.17M sold.
MetLife Investment Management first reported a position in NUVA in Q4 2017 and held it in 23 quarters. The position peaked at $4.01M in Q4 2019. 2 funds tracked by Wall St. Rank hold NUVA as of Q3 2023.
- MetLife Investment Management reported no remaining NuVasive, Inc. position as of Q3 2023 after selling out during the quarter.
- MetLife Investment Management sold 28,150 NuVasive, Inc. shares in Q3 2023, an estimated $1.17M.
- MetLife Investment Management first reported a position in NuVasive, Inc. in Q4 2017 and held it in 23 quarters.
- MetLife Investment Management's NuVasive, Inc. position peaked at $4.01M in Q4 2019.
- 2 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2023.
Based on MetLife Investment Management's 13F filing for Q3 2023, filed 14 Nov 2023.